FIELD: pharmacology.
SUBSTANCE: invention relates to the female sexual dysfunction treatment. The application of the PDE5 inhibitor and the dihydrotestosterone combination is offered. This combination is for the production of the medicinal agent for female sexual disorder treatment, where the noted PDE5 inhibitor (sildenafil, tadalafil or vardenafil) is used in 1-2 hours before the sexual activity and the dihydrotestosterone is in the form of the sublingual preparative form and is used in 3.5-5.5 hours before the sexual activity.
EFFECT: psychological sexual excitement increase.
7 cl, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS AND APPLICATION THEREOF IN TREATING FEMALE SEXUAL DYSFUNCTION | 2005 |
|
RU2436579C2 |
| USE OF TESTOSTERONE AND 5-HT1A AGONIST FOR TREATING SEXUAL DYSFUNCTION | 2007 |
|
RU2463054C2 |
| USE OF TESTOSTERONE ANALOGUE AND 5-HT1A AGONIST FOR SEXUAL DYSFUNCTION TREATMENT | 2012 |
|
RU2646447C2 |
| USING 3-ANDROSTANEDIOL OPTIONALLY IN COMBINATION WITH 5-HT1A ANTAGONIST FOR TREATING SEXUAL DYSFUNCTION | 2007 |
|
RU2491073C2 |
| USE OF 3-ALPHA-ANDROSTENDIOL OPTIONALLY IN COMBINATION WITH PHOSPHODIESTERASE-5 INHIBITOR IN TREATING SEXUAL DYSFUNCTION | 2007 |
|
RU2464027C2 |
| METHOD OF TREATING ERECTILE OR SEXUAL DISORDERS | 2012 |
|
RU2483742C1 |
| METHOD FOR SEXUAL INTEREST (LIBIDO) RECOVERY IN MALES BY PRESCRIBING DIETARY SUPPLEMENTS FOR SEXUAL INTEREST (LIBIDO) RECOVERY IN MALES | 2012 |
|
RU2496491C1 |
| PHARMACEUTICAL COMPOSITION, CONTAINING SILDENAFIL OR ALPROSTADIL, MINOXIDIL OR EUPHYLLIN, TESTOSTERON OR YOHIMBINE AND LIPOSOMES FOR LOCAL APPLICATION | 2010 |
|
RU2482847C2 |
| METHOD FOR TREATING MALE PATIENTS FOR ERECTILE DYSFUNCTION AND HIGH LIBIDO | 2001 |
|
RU2303981C2 |
| USING TRIGONELLA EXTRACT TO ENHANCE FEMALE LIBIDO | 2013 |
|
RU2695351C2 |
